Schönecker, S.; Wischmann, J.; Thunstedt, D.C.; Feil, K.; Mackert, M.J.; Priglinger, S.; Kellert, L.
Retinal Infarction: A Pilot Study on the Efficacy and Safety of Intravenous Thrombolysis and Underlying Aetiologies. Life 2022, 12, 1279.
https://doi.org/10.3390/life12081279
AMA Style
Schönecker S, Wischmann J, Thunstedt DC, Feil K, Mackert MJ, Priglinger S, Kellert L.
Retinal Infarction: A Pilot Study on the Efficacy and Safety of Intravenous Thrombolysis and Underlying Aetiologies. Life. 2022; 12(8):1279.
https://doi.org/10.3390/life12081279
Chicago/Turabian Style
Schönecker, Sonja, Johannes Wischmann, Dennis C. Thunstedt, Katharina Feil, Marc J. Mackert, Siegfried Priglinger, and Lars Kellert.
2022. "Retinal Infarction: A Pilot Study on the Efficacy and Safety of Intravenous Thrombolysis and Underlying Aetiologies" Life 12, no. 8: 1279.
https://doi.org/10.3390/life12081279
APA Style
Schönecker, S., Wischmann, J., Thunstedt, D. C., Feil, K., Mackert, M. J., Priglinger, S., & Kellert, L.
(2022). Retinal Infarction: A Pilot Study on the Efficacy and Safety of Intravenous Thrombolysis and Underlying Aetiologies. Life, 12(8), 1279.
https://doi.org/10.3390/life12081279
